Int J Stomatol

Int J Stomatol ›› 2025, Vol. 52 ›› Issue (2): 183-194.doi: 10.7518/gjkq.2025047

• Original Articles • Previous Articles     Next Articles

Studying how Fusobacterium nucleatum affects the intestinal epithelial barrier model in vitro via the ferroptosis pathway

Xiaoyue Zhang1(),Shuze Chen1,Jieyu Zhou1,Lei Cheng2,Lei Zhao1()   

  1. 1.State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Dept. of Periodontology, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
    2.State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases & Dept. of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2024-05-24 Revised:2024-09-21 Online:2025-03-01 Published:2025-03-01
  • Contact: Lei Zhao E-mail:xiaoyuezhangxxx@163.com;zhaolei@scu.edu.cn
  • Supported by:
    National Natural Science Foundation of China(81970944);Natural Science Foundation of Sichuan Province(2023NSFSC0553);National Natural Science Foundation of China Youth Program(82301089)

RichHTML

9

PDF (PC)

77

Abstract:

Objective This study investigates the effect of Fusobacterium nucleatum (F. nucleatum) infection on the intestinal epithelial barrier in vitro and possible mechanisms. Methods An in vitro intestinal epithelial barrier model was established by inoculating human colorectal adenocarcinoma cells (Caco-2 cells) in Transwell chambers. Dextran sodium sulfate (DSS) and F. nucleatum were used in establishing a cell injury and infection model, and the experimental groups were divided into CON, FN, 8% DSS, and FN+8% DSS groups, where the effects of F. nucleatum on the epithelial bar-riers with and without DSS treatment were detected and the role of ferroptosis in these effects were assessed. Subsequently, the role of ferroptosis inhibition on the damaged epithelial barrier was explored after the introduction of the ferroptosis inhibitors ferrostatin-1 (Fer-1) and deferoxamine (DFO). In the experiments, cell proliferation was detected using cell coun-ting kit 8, and cell damage was detected using lactate dehydrogenase. Epithelial integrity was assessed by trans-epithelial electrical resistance value (TEER). Epithelial permeability was assessed through fluorescein isothiocyanate-dextran (FD4) transmittance, and intercellular junctions and mitochondria were observed through transmission electron microscopy. Western blotting and immunofluorescence staining were used in detecting the expression levels of zonula occludens-1 (ZO-1) and claudin-1 (CLDN-1). Ferroptosis assay included the immunofluorescence staining of intracellular ferrous iron (Fe2+), Western blotting of glutathione peroxidase 4 (GPX4), ferritin heavy chain 1 (FTH1), and acetyl-coenzyme A synthetase long-chain family 4 (ACSL4) expression, and measurement of malondialdehyde (MDA) and glutathione ratio (GSH%) to assess the lipid peroxidation levels. Results Cell proliferation rate decreased, and cell damage increased in the FN, 8% DSS, and FN+8% DSS groups compared with the CON group (P<0.05). No significant differences in TEER values and FD4 permeability were found between the FN and CON groups. TEER values at 6, 12 and 24 h decreased in the FN+8% DSS group compared with the 8% DSS group (P<0.05), and FD4 permeability increased (P<0.000 1). ZO-1 and CLDN-1 proteins were down-regulated in the FN+8% DSS group compared with the CON group (P<0.05). Transmission electron microscopy results showed disruption in intercellular junctions in the 8% DSS and FN+8% DSS groups. F. nucleatum invasion was observed, and mitochondria showed ferroptosis-like alterations. GPX4 protein was down-regula-ted, FTH1 and ACSL4 proteins were up-regulated, intracellular Fe2+ accumulated, MDA level was elevated, and GSH% was reduced. The introduction of Fer-1 and DFO reduced cellular damage and FD4 permeability, resulted in the rebound of TEER va-lues, and elevated the levels of ZO-1 and CLDN-1 proteins (P<0.05). Conclusion F. nucleatum infection may promote DSS-induced gut epithelial barrier disruption in vitro through the ferroptosis pathway.

Key words: Fusobacterium nucleatum, intestinal epithelial barrier, ferroptosis, Caco-2 cell, periodontitis, ulce-rative colitis

CLC Number: 

  • R780.2

TrendMD: 

Fig 1

Proliferation and damage analysis of Caco-2 cells"

Fig 2

Functional assessment of the Caco-2 epithelial monolayer barrier"

Fig 3

Transmission electron microscopic observation of Caco-2 epithelial monolayer"

Fig 4

Expression analysis of Caco-2 epithelial monolayer tight junction proteins"

Fig 5

Assessment of ferroptosis in Caco-2 epithelial monolayer"

Fig 6

Assessment of Caco-2 epithelial monolayer barrier function after the introduction of ferroptosis inhibitors"

1 Janakiram C, Dye BA. A public health approach for prevention of periodontal disease[J]. Periodontol 2000, 2020, 84(1): 202-214.
2 Gurling K. Ulcerative colitis[J]. Postgrad Med J, 1953, 29(327): 2-4.
3 Kucharzik T, Koletzko S, Kannengiesser K, et al. Ulcerative colitis-diagnostic and therapeutic algorithms[J]. Dtsch Arztebl Int, 2020, 117(33/34): 564-574.
4 Lin CY, Tseng KS, Liu JM, et al. Increased risk of ulcerative colitis in patients with periodontal disease: a nationwide population-based cohort study[J]. Int J Environ Res Public Health, 2018, 15(11): 2602.
5 Arenas Rodrigues VA, de Avila ED, Nakano V, et al. Qualitative, quantitative and genotypic evaluation of Aggregatibacter actinomycetemcomitans and Fusobacterium nucleatum isolated from individuals with different periodontal clinical conditions[J]. Anaerobe, 2018, 52: 50-58.
6 Kitamoto S, Kamada N. Periodontal connection with intestinal inflammation: microbiological and immunological mechanisms[J]. Periodontol 2000, 2022, 89(1): 142-153.
7 Brennan CA, Garrett WS. Fusobacterium nucleatum-symbiont, opportunist and oncobacterium[J]. Nat Rev Microbiol, 2019, 17(3): 156-166.
8 Martini E, Krug SM, Siegmund B, et al. Mend your fences: the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel di-sease[J]. Cell Mol Gastroenterol Hepatol, 2017, 4(1): 33-46.
9 Abraham C, Cho JH. Inflammatory bowel disease[J]. N Engl J Med, 2009, 361(21): 2066-2078.
10 Lin SL, Zhang XY, Zhu XZ, et al. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism[J]. J Periodontol, 2023, 94(3): 405-418.
11 Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability[J]. Gastroenterology, 1989, 96(3): 736-749.
12 Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149(5): 1060-1072.
13 Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4[J]. Free Radic Biol Med, 2020, 152: 175-185.
14 Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition[J]. Nat Chem Biol, 2017, 13(1): 91-98.
15 Tang DL, Chen X, Kang R, et al. Ferroptosis: molecular mechanisms and health implications[J]. Cell Res, 2021, 31: 107-125.
16 Kolenbrander PE. Oral microbial communities: biofilms, interactions, and genetic systems[J]. Annu Rev Microbiol, 2000, 54: 413-437.
17 Chen YY, Chen Y, Cao P, et al. Fusobacterium nucleatum facilitates ulcerative colitis through activa-ting IL-17F signaling to NF-κB via the upregulation of CARD3 expression[J]. J Pathol, 2020, 250(2): 170-182.
18 Thurnheer T, Karygianni L, Flury M, et al. Fusobacterium species and subspecies differentially affect the composition and architecture of supra- and subgingival biofilms models[J]. Front Microbiol, 2019, 10: 1716.
19 Qu H, Zhang WJ, Li JH, et al. A rapid and sensitive CRISPR-Cas12a for the detection of Fusobacterium nucleatum [J]. Microbiol Spectr, 2024, 12(2): e0362923.
20 Turner JR. Intestinal mucosal barrier function in health and disease[J]. Nat Rev Immunol, 2009, 9(11): 799-809.
21 Chen YY, Cui WW, Li X, et al. Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease[J]. Front Immunol, 2021, 12: 761981.
22 Liu H, Hong XL, Sun TT, et al. Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation[J]. J Dig Dis, 2020, 21(7): 385-398.
23 Pires CL, Praça C, Martins PAT, et al. Re-use of Caco-2 monolayers in permeability assays-validation regarding cell monolayer integrity[J]. Pharmaceutics, 2021, 13(10): 1563.
24 Dharmani P, Strauss J, Ambrose C, et al. Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha[J]. Infect Immun, 2011, 79(7): 2597-2607.
25 Tang B, Wang K, Jia YP, et al. Fusobacterium nucleatum-induced impairment of autophagic flux enhances the expression of proinflammatory cytokines via ROS in Caco-2 cells[J]. PLoS One, 2016, 11(11): e0165701.
26 Subramanian S, Geng H, Tan XD. Cell death of intestinal epithelial cells in intestinal diseases[J]. Sheng Li Xue Bao, 2020, 72(3): 308-324.
27 Xu MY, Tao J, Yang YD, et al. Ferroptosis involves in intestinal epithelial cell death in ulcerative colitis[J]. Cell Death Dis, 2020, 11(2): 86.
28 Ma DL, Jiang PL, Jiang YJ, et al. Effects of lipid peroxidation-mediated ferroptosis on severe acute pancreatitis-induced intestinal barrier injury and bacterial translocation[J]. Oxid Med Cell Longev, 2021, 2021: 6644576.
29 Tang XM, Liu JQ, Yao S, et al. Ferulic acid allevia-tes alveolar epithelial barrier dysfunction in sepsis-induced acute lung injury by activating the Nrf2/HO-1 pathway and inhibiting ferroptosis[J]. Pharm Biol, 2022, 60(1): 2286-2294.
[1] Jing Li,Jian Kang. Use of regenerated materials in periodontal minimally invasive surgery [J]. Int J Stomatol, 2025, 52(2): 161-168.
[2] Liangjun Zhong. Application of digital technology in the treatment of advanced periodontitis [J]. Int J Stomatol, 2025, 52(1): 1-10.
[3] Shouzheng Cheng,Taiwen Li,Lei Zhao. Research progress on the correlation between serum amyloid A and periodontitis [J]. Int J Stomatol, 2025, 52(1): 117-122.
[4] Mengjie Chen,Wenhua Xu,Qingqing Liu,Yudan Kang,Rong Liu,Lilei Zhu. Correlation analysis between the systemic immune-inflammatory index and graded diagnosis in patients with perio-dontitis [J]. Int J Stomatol, 2024, 51(6): 706-712.
[5] Rui Chen,Zhen Fan,Chunbo Hao. Research progress of absent in melanoma 2 inflammasome in periodontitis and diabetes [J]. Int J Stomatol, 2024, 51(6): 763-771.
[6] Hongchen Mao,Zheng Wang,Deqin Yang. Advances in the role of outer membrane vesicles of Porphyromonas gingivalis in oral diseases and its mechanism [J]. Int J Stomatol, 2024, 51(5): 608-615.
[7] Meiyao Qi,Xingying Qi,Xinyi Zhou,Zhen Tan,Quan Yuan. Therapeutic effect of cannabidiol combined with minocycline on periodontitis [J]. Int J Stomatol, 2024, 51(4): 392-400.
[8] Mengjie Chen, Xiaole Liu, Lilei Zhu. The effect of supportive periodontal therapy on blood cell indicators in patients with periodontitis： a retrospective study [J]. Int J Stomatol, 2024, 51(4): 401-405.
[9] Yu Ma, Yu Zuo, Jianhua Liu. Meta-analysis of the efficacy of antimicrobial photodynamic therapy and systemic antimicrobial drug as an adjunct treatment for periodontitis [J]. Int J Stomatol, 2024, 51(4): 406-415.
[10] Shili Liu, Lei Zhao. Progress of research on the correlation between periodontitis and heart failure [J]. Int J Stomatol, 2024, 51(4): 425-432.
[11] Zaimu Yang,Pei Cao,Zhenhua Liu,Qingxian Luan. Correlation study of plasma cell-free extra-mitochondrial mitochondria DNA and periodontitis clinical parameters [J]. Int J Stomatol, 2024, 51(3): 288-295.
[12] Yuhong Ma,Lei Zhao. Process and progress in the clinical research of minimally invasive non-operative periodontal therapy technology [J]. Int J Stomatol, 2024, 51(2): 227-232.
[13] Fu Yu, He Wei, Huang Lan. Ferroptosis and its implication in oral diseases [J]. Int J Stomatol, 2024, 51(1): 36-44.
[14] Luo Xiaojie,Wang Dexu,Chen Xiaotao. Relationship between periodontitis and ferroptosis based on bioinformatics analysis [J]. Int J Stomatol, 2023, 50(6): 661-668.
[15] Huang Yuanhong,Peng Xian,Zhou Xuedong.. Progress in research into the effect of Rhizoma Drynariae on the treatment of bone-related diseases in the oral cavity [J]. Int J Stomatol, 2023, 50(6): 679-685.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[9] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[10] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .